Skip to main content

Podcast

ACR24 - PSORIATIC ARTHRITIS

A New ACR Apremilast Benefits and Risks in PsA Best Things I Saw Today in PsA Bimekizumab in PsA Showed Sustained Reductions in Disease Impact Biologic Monotherapy vs Combination with cDMARDs in PsA Do TNFis and JAKis Prevent Cancer!? Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Potential

ACR24 - Day4c

Is Frequent Lab Monitoring Necessary?:Dr. Bella Mehta The Case for JAKi in PMR:Dr. David Liew Treatment Strategies in RA:Dr. Victoria Konzett What's New in Relapsing Polychondritis?:Dr. Bella Mehta Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew

ACR24 - Day4b

ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet Pope Apremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway

RheumNow Day 4 Recap ACR Convergence 2024 Highlights

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 - Day4a

ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros Can We Make Clinical Trials Better?:Dr. Janet Pope Cumulative Steroid Use and Cardiovascular Events:Dr.

RheumNow Day 3 Recap ACR Convergence 2024 Highlights

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 -Day3b

Best Things I Saw Today in PsA:Dr. Catherine Bakewell Do TNFis and JAKis Prevent Cancer!?:Dr. Richard Conway Efficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike Putman Evaluating ANA Patterns and Titers with AI:Dr. Bella Mehta Improvements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease Long Term Follow up from APIPPRA:Dr.

ACR24 - Day3a

Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr.

ACR24 - Day2d

Assessment of axSpA:Dr. Antoni Chan Defining Difficult to Manage axSpA:Dr. Lihi DISH in SpA:Dr. Sheila Reyes Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood Native Americans with RA Die Young:Dr. Eric Dein Precision Immunotherapy in Axial SpA:Dr. Marina Magrey When, What and How Long to Treat GCA & PMR:Dr.

ACR24 - Day2c

A Fibroblast Renaissance:Dr. Andrea Fava A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr.

RheumNow Day 2 Recap: ACR Convergence 2024 Highlights

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 - Day2b

JAKi Studies at ACR:Dr. Peter Nash Palliative Care in Rheumatology:Dr. Jiha Lee talks with Dr. Shannon Herndon Estimating Inflammation, Damage and Patient Distress:Dr. Jack Cush talks with Dr. Ted Pincus Methotrexate and the Gut Microbiome:Dr. Jonathan Kay talks with Dr. Rebecca Blank Poly-treatment of Polymyalgia Rheumatica?:Dr.
×